The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
Clinical trial NCT03162562 · TERMINATED
Trial details
- NCT number
- NCT03162562
- Sponsor
- CanariaBio Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2020-11-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.